Imagine a world without cancer.
Immunotherapy expert, Suzanne Topalian, M.D., delivered a presentation to a standing room only crowd at the 2016 American Society of Clinical Oncology (#ASCO16) regarding new… Read More »Can biomarkers predict patients’ response to immunotherapy?
With recent FDA approvals of immunotherapy drugs for kidney and bladder cancer, patients now have more options to consider among their treatments. The 2016 ASCO… Read More »ASCO annual meeting features clinical trial results of immunotherapy for bladder and kidney cancer
A new immunotherapy drug -- the first in its class -- was approved by the Food and Drug Administration last week for bladder cancer. We… Read More »New immunotherapy drug approved to treat bladder cancer
This past weekend, the Avon Foundation held its 14th annual event in Washington, D.C. to raise funds for breast cancer research and education. More than 1,900… Read More »Avon awards Kimmel Cancer Center more than $1 million for breast cancer research and support
In today's lineup of stories covered by WNYC's radio program The Takeaway, Kimmel Cancer Center expert Josh Lauring, M.D., Ph.D., provides his perspective on a new study… Read More »Perspective on a breast cancer genome sequencing study
At the 2016 American Association for Cancer Research annual meeting today, scientists presented their results of a follow-up study tracking the survival of metastatic melanoma… Read More »One-third of patients with metastatic melanoma treated with immunotherapy drug nivolumab survive five years
***Note: This is the final post of a four-part feature story, written by Elizabeth Huebeck. Read part one on Kristin's story, part two on cancer as… Read More »Pay close attention to your overall health
***Note: This is the third of a four-part feature story, written by Elizabeth Huebeck. Read part one on Kristin's story and part two on cancer as a… Read More »Strategies for staying the course
***Note: This is the second of a four-part feature story, written by Elizabeth Huebeck. Read part one on Kristin's story. Statistics show that the five-year survival… Read More »The model patient for cancer as chronic disease
"I, along with the other cancer patients and survivors, have waited more than 20 years to see this day arrive," says Johns Hopkins champion Sidney… Read More »Possibilities – Bloomberg~Kimmel Institute for Cancer Immunotherapy